Ramsay David A
- SEC CIK
- 0001283292
In the past year, 1 open-market sale filing worth $121.2K and no purchases.
Current role at each company
- HALO Halozyme Therapeutics, Inc.EVP, PRESIDENT, DRUG DELIVERYas of Jul 2, 2026
- SVRA Savara IncDirectoras of Dec 19, 2025
- LJPC La Jolla Pharmaceutical CoDirectoras of Aug 24, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $121.2K
- 1 filing
- Net
- −$121.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Ramsay David A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SVRA Savara Inc
Director24 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2021 (view filing) | Aug 17-18 | 2 days | Ramsay David ADirector | PPurchase | +97.3K | $1.19 | +$115.5K | +11.2%964.1K after | 3 lots |
| Sep 30, 2021 (view filing) | Sep 28-30 | 2 days | Ramsay David ADirector | PPurchase | +137.1K | $1.29 | +$176.8K | +14.2%1.10M after | 3 lots |
| Nov 22, 2021 (view filing) | Nov 18-22 | 4 days | Ramsay David ADirector | PPurchase | +200.0K | $1.08 | +$215.5K | +18.2%1.30M after | 3 lots |
| Dec 1, 2021 (view filing) | Nov 30-Dec 1 | 1 day | Ramsay David ADirector | PPurchase | +25.0K | $1.09 | +$27.3K | +1.9%1.33M after | 2 lots |
| Dec 2, 2021 (view filing) | Dec 1-2 | 1 day | Ramsay David ADirector | PPurchase | +25.0K | $1.09 | +$27.2K | +1.9%1.35M after | 2 lots |
| Dec 9, 2021 (view filing) | Dec 7-8 | 2 days | Ramsay David ADirector | PPurchase | +25.0K | $1.05 | +$26.3K | +1.9%1.38M after | 2 lots |
| Dec 13, 2021 (view filing) | Dec 10 | 3 days | Ramsay David ADirector | PPurchase | +35.0K | $1.04 | +$36.4K | +2.5%1.41M after | |
| Dec 17, 2021 (view filing) | Dec 15-17 | 2 days | Ramsay David ADirector | PPurchase | +40.0K | $1.11 | +$44.5K | +2.8%1.45M after | 2 lots |
| Dec 30, 2021 (view filing) | Dec 29-30 | 1 day | Ramsay David ADirector | PPurchase | +50.0K | $1.29 | +$64.3K | +3.4%1.50M after | 2 lots |
| Jun 22, 2022 (view filing) | Jun 17-22 | 5 days | Ramsay David ADirector | PPurchase | +100.0K | $1.39 | +$138.7K | +6.7%1.60M after | 3 lots |
LJPC La Jolla Pharmaceutical Co
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 (view filing) | Nov 17 | 2 days | Ramsay David ADirector | PPurchase | +7.50K | $4.23 | +$31.7K | +11.0%75.5K after | |
| Dec 6, 2021 (view filing) | Dec 2-6 | 4 days | Ramsay David ADirector | PPurchase | +24.5K | $3.75 | +$92.0K | +32.5%100.0K after | 18 lots |